Searching journal content for PI3K/mTOR inhibition (as phrase) in full text.

Displaying results 1-3 of 3
For checked items
  1. ...PI3K/mTOR inhibition in NFPA patients. Pancreas MENX rats develop pancreatic islet hyperplasia (100%), which leads to an increase in islet mass already detectable 2 weeks after birth (Wiedemann et al. 2016a). The pancreatic islets consist of five types of cells each producing a specific hormone. In ~~~
  2. ...PI3K/mTOR inhibition in pheochromocytoma in vivo 10.1530/ERC-16-0324 Misu Lee1,*, Ninelia Minaskan1, Tobias Wiedemann1, Martin Irmler2, Johannes Beckers2,3,4, Behrooz H Yousefi5, Georgios Kaissis6, Rickmer Braren6, Iina Laitinen7,† and Natalia S Pellegata1 1Institute for Diabetes and Cancer, Helmhol ~~~
  3. ...PI3K/mTOR inhibition on PA cellular proliferation and viability One potential pitfall of mTOR inhibition is that mTOR activation normally causes negative feedback on IRS1. O’Reilly et al. (2006) reported that inhibition of mTOR by rapamycin does indeed cause a decrease in p70S6K, abolishing its nega ~~~
For checked items